Cargando...
Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence
Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy. Therapy with anti-tumor necrosis factor (TNF)-α agents represents the first therapeutic choice for moderate and severe forms; however, PsA patients can experience anti-TNFα failure, lack of efficacy, or adverse events. Several evidence...
Gardado en:
| Publicado en: | Drugs R D |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5694428/ https://ncbi.nlm.nih.gov/pubmed/29058302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-017-0215-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|